The Permissible Indication Determination (No. 2) 2019 has been published on the Federal Register of Legislation and commenced on the 14th November 2020. It replaces the Therapeutic Goods (Permissible Indications) Determination (No. 1) 2019.

New listings must comply with the updated requirements from the 14th November 2019. Existing listings need to be updated by 6th March 2021.

The changes include;

8 new indications added

  • Decrease/reduce/relieve urinary urgency associated w